Evidence map›Paper›PMID 41008479›Full record

ReviewHealthcare (Basel, Switzerland)2025

Reproductive and Fertility Care of Women with Schizophrenia: A Narrative Review.

Alexandre González-Rodríguez, José Antonio Monreal, Mentxu Natividad, Jesús Cobo, Bruma Palacios-Hernández, Leah C Susser

Abstract readReview
In one paragraph

Review in Healthcare (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alexandre González-RodríguezDepartment of Mental Health, Mutua Terrassa University Hospital, Fundació Docència I Recerca Mutua Terrassa, University of Barcelona (UB), 5 Doctor Robert Square, 08221 Terrassa, Spain.ORCID 0000-0003-1855-8566
José Antonio MonrealDepartment of Mental Health, Mutua Terrassa University Hospital, Fundació Docència I Recerca Mutua Terrassa, University of Barcelona (UB), 5 Doctor Robert Square, 08221 Terrassa, Spain.ORCID 0000-0002-0906-927X
Mentxu NatividadDepartment of Mental Health, Mutua Terrassa University Hospital, Fundació Docència I Recerca Mutua Terrassa, University of Barcelona (UB), 5 Doctor Robert Square, 08221 Terrassa, Spain.
Jesús CoboDepartment of Mental Health, Parc Taulí University Hospital, Autonomous University of Barcelona (UAB), 1 Parc Taulí, 08208 Sabadell, Spain.ORCID 0000-0002-2032-9343
Bruma Palacios-HernándezPerinatal Mental Health Research Laboratory CITPsi-UAEM, Autonomous University of the State of Morelos, 1001 Universidad Avenue, Colonia Chamilpa, Cuernavaca 62350, Mexico.ORCID 0000-0002-0233-2717
Leah C SusserWeill Cornell Medicine, 21 Bloomingdale Road, White Plains, NY 10605, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Women with schizophrenia have specific reproductive and fertility care needs that differ from those of men. This narrative review aims to explore the reproductive and fertility care needs of women with schizophrenia related to fertility, menstrual cycle, family planning, and the perinatal period. Hormonal fluctuations in the menstrual cycle can significantly affect clinical symptoms and the efficacy of contraceptive treatments in women with schizophrenia. When undergoing fertility treatment, attention should be given to the potential interactions between fertility treatment drugs and antipsychotics, as well as the potential impact of antipsychotics on the ability to conceive. Although pregnancy rates and participation in fertility programs have increased among women with schizophrenia, very little information is available on the safety and efficacy of fertility treatments in women with severe psychotic disorders. This is an area that warrants further study. Mobilizing social supports and optimizing medication are important components of the treatment of schizophrenia in the perinatal period and are important for the health and safety of infants and mothers. In conclusion, preventing relapse and promoting physical and mental health in this group of women during successive reproductive periods of life is vital and requires an emphasis on the social and psychiatric context, as well as the biological changes occurring at these times.

Indexed as

contraceptionfamily planningfertilitypostpartumpregnancypsychosisschizophrenia

Identifiers

PMID41008479
PMCPMC12469327

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.